| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/19/1999 | EP0915977A1 B. burgdorferi polypeptides expressed in vivo |
| 05/19/1999 | EP0915973A1 Gene involved in cadasil, method of diagnosis and therapeutic application |
| 05/19/1999 | EP0915969A1 Method for preventing hiv-1 infection of cd4+ cells |
| 05/19/1999 | EP0915710A2 Stable radioiodine conjugates and methods for their synthesis |
| 05/19/1999 | EP0915709A1 The use of proteinase inhibitors for prevention or reduction of bone resorption |
| 05/19/1999 | EP0915708A1 Cancer immunotherapy using autologous tumor cells combined with allogeneic cytokine-secreting cells |
| 05/19/1999 | EP0915706A1 Screening methods for compounds useful in the regulation of body weight |
| 05/19/1999 | EP0915648A1 Methods and compositions for the selective modification of nucleic acids |
| 05/19/1999 | EP0574466B1 Expression of recombinant proteins in attenuated bacteria |
| 05/19/1999 | EP0434747B1 RECOMBINANT VACCINES BASED ON THE gB-PROTEIN OF MAREK'S DISEASE VIRUS |
| 05/19/1999 | CN1217027A Parapoxviruses contg. foreign DNA, their prodn. and their use in vacciens |
| 05/19/1999 | CN1216994A Apoptosis inducing molecule II |
| 05/19/1999 | CN1216922A Porcine reproductive and respiratory syndrome vaccine |
| 05/19/1999 | CN1216712A Traditional Chinese medicine for treating cancer |
| 05/18/1999 | US5905040 Eukaryotic transfectants express self-assembled empty viral capsids which can be used to vaccinate against the virus or antigenically related species of the virus. |
| 05/18/1999 | US5904925 Comprising polydimethylsiloxane, emulsifier, salt solution, dimethylsulfoxide and chelating agent |
| 05/18/1999 | US5904922 Purified chicken antivenom in aqueous solution |
| 05/18/1999 | US5904920 Regulation of systemic immune responses utilizing cytokines and antigens |
| 05/18/1999 | US5904144 Method for delivering a biologically active molecule to the eye |
| 05/18/1999 | CA1340544C Human tissue factor related dna segments, polypeptides and antibodies |
| 05/14/1999 | WO1999023230A1 Reagents and methods useful for detecting diseases of the breast |
| 05/14/1999 | WO1999023227A2 Hyaluronan synthase gene and uses thereof |
| 05/14/1999 | WO1999023221A2 Multivalent antigen-binding proteins |
| 05/14/1999 | WO1999023217A1 A novel gene and uses therefor |
| 05/14/1999 | WO1999023212A1 Novel streptococcal ers |
| 05/14/1999 | WO1999023107A1 Modification of virus tropism and host range by viral genome shuffling |
| 05/14/1999 | WO1999022766A2 Use of anti-il-12 antibodies in transplantation rejection |
| 05/14/1999 | WO1999022765A1 Control of lymphocyte localization by leep-cam activity |
| 05/14/1999 | WO1999022764A1 Methods and compositions comprising glycoprotein glycoforms |
| 05/14/1999 | WO1999022763A2 Encapsulated immunomodulators useful as vaccine adjuvants |
| 05/14/1999 | WO1999022762A1 Tolerogenic fragments of natural allergens |
| 05/14/1999 | WO1999022761A1 Conjugate heat shock protein-binding peptides |
| 05/14/1999 | WO1999022750A1 Vision improving eye solution |
| 05/14/1999 | WO1999014345A3 Medicament for treating a manifested lyme disease |
| 05/14/1999 | WO1999007839A3 Immunoprotective influenza antigen and its use in vaccination |
| 05/14/1999 | WO1999006068A3 Recombinant dimeric envelope vaccine against flaviviral infection |
| 05/14/1999 | WO1999004265A8 Cancer associated nucleic acids and polypeptides |
| 05/14/1999 | WO1999002183A3 A method of inducing a ctl response |
| 05/14/1999 | WO1998058965A3 B7-binding molecules for treating immune diseases |
| 05/14/1999 | WO1998053799A9 Immunogenic compositions |
| 05/14/1999 | WO1998052603A3 An influenza enveloped dna vaccine |
| 05/14/1999 | WO1998052582A9 Non-myeloablative tolerogenic treatment |
| 05/14/1999 | WO1998047480A3 Membrane system for controlled tissue regeneration in cases of diseases of the peridontium |
| 05/14/1999 | WO1998014593A9 Human telomerase catalytic subunit |
| 05/14/1999 | CA2308299A1 Conjugate heat shock protein-binding peptides |
| 05/14/1999 | CA2308029A1 Reagents and methods useful for detecting diseases of the breast |
| 05/14/1999 | CA2307839A1 Gene involved in metabolic energy and obesity |
| 05/14/1999 | CA2307541A1 Encapsulated immunomodulators useful as vaccine adjuvants |
| 05/14/1999 | CA2307166A1 Methods and compositions comprising glycoprotein glycoforms |
| 05/14/1999 | CA2276420A1 Use of anti-il-12 antibodies in transplantation rejection |
| 05/14/1999 | CA2254383A1 Novel fabh |
| 05/12/1999 | EP0915164A2 RncS, a ribonuclease from Staphylococcus aureus |
| 05/12/1999 | EP0915162A2 Adenine phosphoribosyltransferase |
| 05/12/1999 | EP0915161A2 DnaG DNA primase of Streptococcus pneumoniae |
| 05/12/1999 | EP0915159A1 Novel xanthine phosphoribosyl transferase |
| 05/12/1999 | EP0914831A2 Biological product for preventive or therapeutic oral administration against canine parvovirosis |
| 05/12/1999 | EP0914614A1 CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrP?c AND PrP?sc |
| 05/12/1999 | EP0914456A1 Gene expression in monocytes and macrophages |
| 05/12/1999 | EP0914453A1 HUMAN INTERLEUKIN-1j AND ANTAGONISTS THEREOF |
| 05/12/1999 | EP0914448A1 Lipid kinase |
| 05/12/1999 | EP0914442A1 Avian polynucleotide vaccine formula |
| 05/12/1999 | EP0914441A2 Novel human cytomegalovirus dna constructs and uses therefor |
| 05/12/1999 | EP0914440A1 Nucleic acid vaccination for parvoviral infections |
| 05/12/1999 | EP0914437A2 Identification and cloning of a mycobacterial antigen corresponding to a heparin-binding haemagglutinin |
| 05/12/1999 | EP0914434A2 Method for preparing transgenic non-human mammalian organs for transplantation to humans, and nucleotide sequences therefor |
| 05/12/1999 | EP0914428A2 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
| 05/12/1999 | EP0914427A1 Plasmid-based vaccine for treating atherosclerosis |
| 05/12/1999 | EP0914422A1 Mammalian genes involved in viral infection and tumor suppression |
| 05/12/1999 | EP0914416A1 Method for the production of activated marked tumor-specific t cells and use thereof in treatment of tumors |
| 05/12/1999 | EP0914346A1 THERAPEUTIC MULTISPECIFIC COMPOUNDS COMPRISED OF ANTI-FC$g(a) RECEPTOR ANTIBODIES |
| 05/12/1999 | EP0914345A1 Antibodies binding to monocyte chemoattractant protein 1 (mcp-1) receptor (ccr2) |
| 05/12/1999 | EP0914339A2 RET LIGAND (RetL) FOR STIMULATING NEURAL AND RENAL GROWTH |
| 05/12/1999 | EP0914335A2 Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer |
| 05/12/1999 | EP0914330A1 Novel compounds |
| 05/12/1999 | EP0914328A1 STREPTOCOCCUS PNEUMONIAE ALANYL tRNA SYNTHETASE |
| 05/12/1999 | EP0914327A1 NOVEL LysS PROTEINS FROM STREPTOCOCCUS PNEUMONIAE |
| 05/12/1999 | EP0914202A1 Preservation by foam formation |
| 05/12/1999 | EP0914168A1 New medicaments containing gelatin cross-linked with oxidized polysaccharides |
| 05/12/1999 | EP0914166A1 Methods of terminal sterilization of biological products |
| 05/12/1999 | EP0914163A1 Novel processes implementing selective immune down regulation (sidr) |
| 05/12/1999 | EP0914157A1 Anti-tnf antibodies and methotrexate in the treatment of autoimmune disease |
| 05/12/1999 | EP0914156A1 Passively administered antibody that enhances feed conversion efficiency |
| 05/12/1999 | EP0914155A1 Monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen |
| 05/12/1999 | EP0914154A1 Chitosan induced immunopotentiation |
| 05/12/1999 | EP0914153A1 Multivalent dtp-polio vaccines |
| 05/12/1999 | EP0914152A1 Immunogenic complex, use, method of preparation thereof and vaccine containing same |
| 05/12/1999 | EP0914151A1 Complex comprising antigen and cell constituent, method of preparing said complex and its therapeutic uses |
| 05/12/1999 | EP0914150A1 Recombinant neospora antigens and their uses |
| 05/12/1999 | EP0914142A1 Peptides with increased binding affinity for hla molecules |
| 05/12/1999 | EP0914141A1 Stabilized antihepatitis-b vaccine tablets |
| 05/12/1999 | EP0914140A1 Parasitic helminth larval thiol specific antioxidant proteins, nucleic acid molecules, and uses thereof |
| 05/12/1999 | EP0914134A1 Adjuvant properties of poly(amidoamine) dendrimers |
| 05/12/1999 | EP0914114A1 Methods of treating type i hypersensitivity using monophosphoryl lipid a |
| 05/12/1999 | EP0914041A1 Methods and compositions for suppressing an immune response using major histocompatibility complex (mhc) class ii peptides |
| 05/12/1999 | EP0789710B1 Peptides for anti-allergy treatment |
| 05/12/1999 | EP0754230B1 Agonist antibodies against the flk2/flt3 receptor and uses thereof |
| 05/12/1999 | EP0668923B1 Monoclonal antibody |
| 05/12/1999 | EP0527752B1 Expression of bordetella pertactin antigens in pichia |
| 05/12/1999 | CN1216584A Immunity to trypanosomatids species |
| 05/12/1999 | CN1216471A Stabilized antihepatitis-B vaccine tablets |